All posts

Exco Technologies is still a pass, says Industrial Alliance

Better-than-expected EBITDA margins in the latest quarter for Exco Technologies (TSX:XTC) were not enough to move the needle for analyst Nav Malik of Industrial Alliance Securities. In a research update on Thursday, Malik reiterated his “Hold” rating while raising his target price from $10.25 to $10.50.

A global supplier to the die-cast, extrusion and automotive industries, Exco Technologies reported its first quarter 2019 ended December 31 results on Wednesday, showing sales of $142.1 million and Adjusted EBITDA of $20.6 million. Exco’s top line represents a 5.4 per cent year-over-year uptick in revenue, while the Adjusted EBITDA was 6.6 per cent higher year-over-year.

Malik says that revenue arrived in line with his expectations but that at 15.5 per cent the EBITDA margins were about a percentage point higher than his forecast. Overall, Malik says the quarterly results were slightly higher than his expectations but that he’s making no changes to his outlook and estimates.

“While company-specific and macro challenges persist (i.e., competitive pricing pressure, higher labour costs, and raw material cost inflation), we view Exco’s initiatives to improve operational efficiency, target specific organic growth opportunities and focus on higher margin products as positive. In addition, the Company has a clean balance sheet and pays a sustainable dividend,” says the analyst.

Exco announced a dividend increase from $0.085 per share to $0.09 per share, along with the appointment of Darren Kirk as President and CEO, with Kirk having previously served as COO since January of last year.

Malik’s $10.50 target represents a projected return of 12.3 per cent at the time of publication.

Tagged with: xtc
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Cannara Biotech is a buy, Research Capital says

Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech Stock Quote, Chart, News,… [Read More]

14 hours ago

Ahead of Q2 results, is Tantalus Systems a buy?

Beacon Securities analyst Gabriel Leung noted in a July 30 report that Tantalus Systems (Tantalus Systems Holding Stock Quote, Chart,… [Read More]

14 hours ago

Sanuwave Health is a buy, Roth Capital says

Roth Capital Markets is initiating coverage of Sanuwave Health (Sanuwave Health Stock Quote, Chart, News, Analysts, Financials NASDAQ:SNWV) with a… [Read More]

14 hours ago

Shoulder Innovations is an IPO to watch, this analyst says

Roth Capital Markets analyst Jason Wittes noted in a July 28 pre-IPO report that Shoulder Innovations, a new entrant in… [Read More]

15 hours ago

Nextracker wins price target raise at Roth

Roth Capital Markets analyst Philip Shen said in a July 28 earnings preview that Nextracker (Nextracker Stock Quote, Chart, News,… [Read More]

15 hours ago

Telus is my top telecom stock, Brian Madden says

Brian Madden, Chief Investment Officer at First Avenue Investment Counsel, said on BNN Bloomberg’s Market Call on July 25 that… [Read More]

1 day ago